2: PN: US20040072744 SEQID: 2 claimed protein

2: PN: US20040072744 SEQID: 2 claimed protein is a synthetic peptide sequence derived from the intellectual property referenced in US patent application US20040072744, specifically corresponding to SEQ ID NO: 2. As a custom peptide, it represents a precisely defined amino acid sequence that can serve as a functional mimic, epitope, or molecular probe in biochemical research. Its sequence-specific nature enables targeted investigations into protein-protein interactions, structural biology, and functional assays, making it a valuable tool for elucidating molecular mechanisms and validating hypotheses in proteomics, immunology, and related fields.

Epitope Mapping: In immunological research, this synthetic peptide is frequently utilized for epitope mapping to identify antibody recognition sites within larger proteins. By synthesizing and testing overlapping or discrete peptide segments, researchers can pinpoint the specific amino acid motifs responsible for antigen-antibody interactions. The defined sequence of SEQ ID NO: 2 allows for accurate characterization of immune responses, supporting the development of monoclonal antibodies, diagnostic reagents, and vaccine candidates.

Protein-Protein Interaction Studies: The peptide can serve as a molecular probe for dissecting protein-protein interactions in vitro. By immobilizing or labeling this sequence, investigators can examine the binding affinities and specificities of potential interacting partners. Such studies are instrumental in mapping interaction domains, validating computational predictions, and screening for inhibitors or modulators in drug discovery pipelines.

Functional Assays: As a bioactive sequence, the peptide offers utility in functional assays designed to probe the biological activity of the parent protein or its homologs. Researchers can employ it to assess receptor binding, signal transduction, or enzymatic modulation in cell-free systems or cultured cells. Its synthetic origin and precise composition facilitate controlled experimental conditions, enabling reproducible measurements and mechanistic insights.

Antibody Production: The sequence-specific nature of this peptide makes it an ideal immunogen for generating polyclonal or monoclonal antibodies. When conjugated to suitable carrier proteins, it can elicit targeted immune responses in host animals, yielding antibodies with high specificity toward the native protein or conserved motifs. Such antibodies are invaluable in Western blotting, ELISA, immunoprecipitation, and other analytical techniques.

Peptide-Based Inhibitor Design: The defined primary structure of the peptide provides a template for rational design of competitive inhibitors or mimetics. By modeling interactions between the peptide and its biological targets, researchers can develop analogs or derivatives with enhanced binding properties or altered functional profiles. This approach supports the identification of lead compounds for further optimization in biochemical or pharmacological studies.

1. Therapeutic potential of an intestinotrophic hormone, glucagon-like peptide 2, for treatment of type 2 short bowel syndrome rats with intestinal bacterial and fungal dysbiosis

2. Uncarboxylated osteocalcin decreases insulin-stimulated glucose uptake without affecting insulin signaling and regulators of mitochondrial biogenesis in myotubes

3. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)

4. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

5. TMEM16F and dynamins control expansive plasma membrane reservoirs